CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net service revenue	$ 2,348,324	$ 2,236,382	$ 2,223,199
Cost of service, inclusive of depreciation	1,330,647	1,245,509	1,260,425
General and administrative expenses:
Salaries and benefits	529,748	516,049	508,791
Non-cash compensation	29,028	26,082	16,560
Merger-related expenses	66,638	36,672	0
Depreciation and amortization	17,997	17,747	24,935
Impairment	48,391	0	3,009
Other	231,337	237,929	228,707
Total operating expenses	2,253,786	2,079,988	2,042,427
Operating income	94,538	156,394	180,772
Other income (expense):
Interest income	8,110	3,270	178
Interest expense	(30,764)	(31,274)	(22,228)
Equity in earnings (loss) from equity method investments	6,267	10,760	(45)
Merger termination fee	0	(106,000)	0
Miscellaneous, net	8,065	6,473	1,567
Total other expense, net	(8,322)	(116,771)	(20,528)
Income before income taxes	86,216	39,623	160,244
Income tax expense	(48,054)	(50,559)	(42,545)
Net income (loss)	38,162	(10,936)	117,699
Net loss attributable to noncontrolling interests	5,069	1,189	910
Net income (loss) attributable to Amedisys, Inc.	$ 43,231	$ (9,747)	$ 118,609
Basic earnings per common share:
Net income (loss) attributable to Amedisys, Inc. common stockholders (usd per share)	$ 1.32	$ (0.30)	$ 3.65
Weighted average shares outstanding (shares)	32,718	32,599	32,517
Diluted earnings per common share:
Net income (loss) attributable to Amedisys, Inc. common stockholders	$ 1.31	$ (0.30)	$ 3.63
Weighted average shares outstanding (shares)	33,051	32,599	32,653